Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2021		83,659,665
Beginning balance at Dec. 31, 2021	$ 807,078	$ 8	$ 740,849	$ 66,221
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		1,804,373
Issuance of common stock upon exercise of stock options	9,407	$ 1	9,406
Issuance of common stock upon settlement of restricted stock units (in shares)		179,878
Stock-based compensation expense	58,376		58,376
Issuance of common stock under employee stock purchase plan (in shares)		47,894
Issuance of common stock under employee stock purchase plan	4,431		4,431
Repurchases of stock (in shares)		(3,503,438)
Repurchases of stock	(125,042)	$ (1)	(125,041)
Net income (loss)	2,821			2,821
Ending balance (in shares) at Jun. 30, 2022		82,188,372
Ending balance at Jun. 30, 2022	757,071	$ 8	688,021	69,042
Beginning balance (in shares) at Mar. 31, 2022		84,676,746
Beginning balance at Mar. 31, 2022	876,504	$ 9	777,582	98,913
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		915,412
Issuance of common stock upon exercise of stock options	3,781	$ 0	3,781
Issuance of common stock upon settlement of restricted stock units (in shares)		99,652
Stock-based compensation expense	31,699		31,699
Repurchases of stock (in shares)		(3,503,438)
Repurchases of stock	(125,042)	$ (1)	(125,041)
Net income (loss)	(29,871)			(29,871)
Ending balance (in shares) at Jun. 30, 2022		82,188,372
Ending balance at Jun. 30, 2022	$ 757,071	$ 8	688,021	69,042
Beginning balance (in shares) at Dec. 31, 2022	81,259,676	81,259,676
Beginning balance at Dec. 31, 2022	$ 672,435	$ 8	714,871	(42,444)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	770,693	770,693
Issuance of common stock upon exercise of stock options	$ 6,672		6,672
Issuance of common stock upon settlement of restricted stock units (in shares)		1,469,356
Shares withheld related to net share settlement of restricted stock units (in shares)		(375)
Shares withheld related to net share settlement of restricted stock units	(6)		(6)
Stock-based compensation expense	110,735		110,735
Issuance of common stock under employee stock purchase plan (in shares)		312,134
Issuance of common stock under employee stock purchase plan	5,728		5,728
Net income (loss)	$ (157,419)			(157,419)
Ending balance (in shares) at Jun. 30, 2023	83,811,484	83,811,484
Ending balance at Jun. 30, 2023	$ 638,145	$ 8	838,000	(199,863)
Beginning balance (in shares) at Mar. 31, 2023		82,600,748
Beginning balance at Mar. 31, 2023	627,208	$ 8	798,898	(171,698)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		439,600
Issuance of common stock upon exercise of stock options	5,135		5,135
Issuance of common stock upon settlement of restricted stock units (in shares)		771,183
Shares withheld related to net share settlement of restricted stock units (in shares)		(47)
Shares withheld related to net share settlement of restricted stock units	(1)		(1)
Stock-based compensation expense	33,968		33,968
Net income (loss)	$ (28,165)			(28,165)
Ending balance (in shares) at Jun. 30, 2023	83,811,484	83,811,484
Ending balance at Jun. 30, 2023	$ 638,145	$ 8	$ 838,000	$ (199,863)